Cargando…
Corticosteroid use in selected patients with severe acute respiratory distress syndrome related to COVID-19
Autores principales: | Goursaud, Suzanne, Descamps, Richard, Daubin, Cédric, du Cheyron, Damien, Valette, Xavier |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The British Infection Association. Published by Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7224654/ https://www.ncbi.nlm.nih.gov/pubmed/32417314 http://dx.doi.org/10.1016/j.jinf.2020.05.023 |
Ejemplares similares
-
Ultraprotective ventilation allowed by extracorporeal CO(2) removal improves the right ventricular function in acute respiratory distress syndrome patients: a quasi-experimental pilot study
por: Goursaud, Suzanne, et al.
Publicado: (2021) -
Mediastinal lymphadenopathy in patients with severe COVID-19
por: Valette, Xavier, et al.
Publicado: (2020) -
COVID-19 necrotising pneumonia and extracorporeal membrane oxygenation: a challenge for anticoagulation
por: Goursaud, Suzanne, et al.
Publicado: (2020) -
Corticosteroid Administration Is Associated With Improved Outcome in Patients With Severe Acute Respiratory Syndrome Coronavirus 2-Related Acute Respiratory Distress Syndrome
por: Chopra, Amit, et al.
Publicado: (2020) -
Ability of procalcitonin to distinguish between bacterial and nonbacterial infection in severe acute exacerbation of chronic obstructive pulmonary syndrome in the ICU
por: Daubin, Cédric, et al.
Publicado: (2021)